Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3 | 41841413 | intron variant | G/C | snv | 0.33 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
3 | 41353856 | intron variant | T/A | snv | 8.5E-04 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
3 | 41827229 | intron variant | T/C | snv | 0.27 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
3 | 41405099 | intron variant | T/C | snv | 4.9E-05 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
3 | 41396140 | intron variant | A/G | snv |
|
0.700 | 1.000 | 1 | 2015 | 2015 | |||||||||||
|
3 | 41376349 | intron variant | A/C;G | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
3 | 41569737 | intron variant | T/G | snv | 0.56 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
3 | 41880318 | intron variant | C/T | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
3 | 41880318 | intron variant | C/T | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
3 | 41269871 | intron variant | G/C | snv | 0.31 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.851 | 0.160 | 3 | 41709497 | intron variant | T/C | snv | 0.30 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.800 | 1.000 | 2 | 2011 | 2017 | |||||||
|
0.851 | 0.160 | 3 | 41709497 | intron variant | T/C | snv | 0.30 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 3 | 41709497 | intron variant | T/C | snv | 0.30 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 3 | 41709497 | intron variant | T/C | snv | 0.30 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.160 | 3 | 41786808 | intron variant | A/G | snv | 0.12 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.800 | 1.000 | 2 | 2011 | 2015 | |||||||
|
0.882 | 0.160 | 3 | 41786808 | intron variant | A/G | snv | 0.12 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.160 | 3 | 41786808 | intron variant | A/G | snv | 0.12 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.160 | 3 | 41712155 | intron variant | C/T | snv | 0.18 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 3 | 41712155 | intron variant | C/T | snv | 0.18 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 3 | 41712155 | intron variant | C/T | snv | 0.18 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.160 | 3 | 41883906 | missense variant | C/G;T | snv | 0.80 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.810 | 1.000 | 3 | 2011 | 2014 | |||||||
|
0.925 | 0.160 | 3 | 41871159 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 3 | 2009 | 2017 | |||||||||
|
0.925 | 0.160 | 3 | 41883906 | missense variant | C/G;T | snv | 0.80 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.160 | 3 | 41871159 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
0.925 | 0.160 | 3 | 41871159 | intron variant | G/A;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 |